Semaglutide Therapy in Lakeland, FL

Understand semaglutide before choosing treatment.

Semaglutide is a GLP-1 receptor agonist. Specific approved products have specific indications and instructions.

How it supports weight management

Semaglutide can reduce appetite and calorie intake. When an appropriate weight-management product is prescribed, treatment accompanies nutrition and physical activity changes.

Know the exact product

Wegovy is a semaglutide brand with weight-management indications. Other semaglutide brands have different indications and dosing instructions. Ask your provider which product and formulation are proposed.

Approved and compounded products differ

Compounded semaglutide is not FDA-approved and is not equivalent to an approved brand. Your consultation should clarify the formulation, source, regulatory status and why it is proposed.

Could semaglutide be appropriate for you?

Your provider reviews eligibility, potential benefit and individual risk before prescribing.

• You want medical help evaluating weight-management options.
• You can participate in nutrition, activity and follow-up care.
• You are willing to discuss your full health and medication history.
• You understand that response and tolerance vary.

Eligibility and contraindications

Common adult weight-management criteria include obesity, or overweight with a weight-related condition; product-specific requirements apply. Semaglutide is contraindicated with a personal or family history of medullary thyroid carcinoma, MEN2 or a serious allergy to the product.

Important precautions

Discuss pregnancy plans, breastfeeding, pancreatitis, gallbladder disease, kidney problems, severe gastroparesis and diabetic eye disease. Weight-management treatment is not used during pregnancy; discuss stopping semaglutide at least two months before a planned pregnancy. Tell your provider about insulin, sulfonylureas and any other GLP-1 or semaglutide medication.